Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feedergsk.com
Get the latest updates from Press releases directly as they happen.
Follow now 471 followers
Last updated 4 days ago
4 days ago
Studies from OPERA and Trio cohorts provide further real-world evidence.
5 days ago
Gepotidacin could be the first in a new class of oral antibiotic...
7 days ago
Depemokimab is an ultra-long-acting biologic administered once every six months
10 days ago
60 abstracts to be presented across broad and growing portfolio of vaccines...
11 days ago
GSK to resolve 93% (approximately 80,000 cases) of U.S. state court Zantac...
12 days ago
GSK’s RSV vaccine is the only RSV vaccine with efficacy and safety...
13 days ago
At least two million doses of long-acting cabotegravir for PrEP to be...
26 days ago
Marketing authorisation in EU expected by November 2024.
about 1 month ago
GSK confirmed it has reached two confidential settlements in cases filed in...
about 1 month ago
Regulatory submission supported by phase III head-to-head DREAMM-7 and DREAMM-8 trials.
about 1 month ago
Granted based on results from phase III head-to-head DREAMM-7 trial.
about 1 month ago
Data support progression to phase III clinical trials.